Pharma R&D & Clinical Services · Indirect
Monitoring · monthlyProcurement Category Intelligence
Phase II Clinical Trials
Overview
Market size
$7.2B
global, USD
CAGR
7.5%
base to forecast
Buyer power
-2.0
supplier-favoured
Suppliers
6
tracked players
Signals
12
6 high severity
Market outlook
2031$10.3B
What changed
Demand by region
North America demand45%
Europe demand30%
Asia-Pacific demand15%
Rest of world demand10%
share of global demandtotal 100%
Cost drivers
Clinical monitoring and site management labor35%
Project management and data analytics labor25%
Investigator grants and clinical site fees15%
Patient recruitment and retention services15%
Regulatory compliance and trial logistics10%
share of delivered cost (analyst estimate)